| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.6M | — | +0.0% |
| Cost of Revenue | $1.5M | — | +0.0% |
| Gross Profit | $81K | — | +0.0% |
| R&D Expense | $66K | — | +0.0% |
| SG&A Expense | $787K | — | +172.0% |
| Operating Income | -$787K | — | -186.5% |
| Pre-tax Income | -$884K | — | -220.1% |
| Net Income | -$682K | — | -220.8% |
| EPS (Basic) | -$0.03 | — | -200.0% |
| EPS (Diluted) | -$0.03 | — | -200.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $3.1M | -4.2% | +24.4% |
| Inventory | $114K | +1.5% | -95.3% |
| Current Assets | $6.8M | +0.2% | +13.6% |
| Total Assets | $26.8M | -0.6% | -6.7% |
| Current Liabilities | $13.7M | +4.4% | +8.1% |
| Total Liabilities | $15.6M | +3.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$709K | — | +56.4% |
| Capital Expenditures | $88K | — | +0.0% |
| Investing Cash Flow | -$88K | — | +0.0% |
| Financing Cash Flow | $200K | — | -85.9% |
| Free Cash Flow | -$797K | — | +53.5% |
| +5.8% |
| Stockholders' Equity | $8.2M | -6.2% | -20.9% |